Published in Br J Clin Pharmacol on February 01, 2005
Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003. Br J Clin Pharmacol (2005) 1.93
Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health (2006) 1.43
Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Fam Pract (2009) 1.16
Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy. Br J Clin Pharmacol (2009) 1.01
Understanding the effects of a decentralized budget on physicians' compliance with guidelines for statin prescription--a multilevel methodological approach. BMC Health Serv Res (2007) 0.99
Patterns and predictors of statin prescription in patients with type 2 diabetes. Cardiovasc Diabetol (2009) 0.99
General practitioners' ranking of evidence-based prescribing quality indicators: a comparative study with a prescription database. Br J Clin Pharmacol (2006) 0.91
Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care (2013) 0.87
Statin wars following coronary revascularization--evidence-based clinical practice? Can J Cardiol (2006) 0.85
Time trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care data. Clin Epidemiol (2016) 0.82
Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England. BMJ Open (2015) 0.81
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. Br J Clin Pharmacol (2006) 0.79
The darkening cloud of diabetes: do trends in cardiovascular risk management provide a silver lining? Diabetes Care (2008) 0.75
Monitoring the use of lipid-lowering medication among persons with newly diagnosed diabetes: a nationwide register-based study. BMJ Open (2013) 0.75
Trends in statin therapy initiation during the period 2000-2010 in Israel. Eur J Clin Pharmacol (2014) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 9.18
Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J (1998) 5.09
Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet (1988) 4.01
Influences on GPs' decision to prescribe new drugs-the importance of who says what. Fam Pract (2003) 3.38
Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records. BMJ (2000) 2.90
The role of commercial sources in the adoption of a new drug. Soc Sci Med (1988) 2.75
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart (1999) 2.69
Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med (2003) 2.56
Randomised controlled trial of the impact of guidelines, prioritized review criteria and feedback on implementation of recommendations for angina and asthma. Br J Gen Pract (2003) 2.40
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20
The lipid and non-lipid effects of statins. Pharmacol Ther (2003) 1.29
Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. Br J Clin Pharmacol (2003) 1.24
The influence of hospital-based prescribers on prescribing in general practice. Pharmacoeconomics (1999) 1.23
The therapeutic gap--compliance with medication and guidelines. Atherosclerosis (1999) 0.94
Growth in use of statins after trials is not targeted to most appropriate patients. Clin Pharmacol Ther (2000) 0.90
Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians. Eur J Heart Fail (2003) 0.88
The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF Group. Pharmacoeconomics (2001) 0.86
A safety look at currently available statins. Expert Opin Drug Saf (2002) 0.86
Gap between guidelines and management of patients with acute coronary syndrome without persistent ST elevation. Finnish prospective follow-up survey. Scand Cardiovasc J (2003) 0.82
The prescribing of lipid lowering drugs during a 1-year period: analysis of 7490 health insurance files. Pharmacoepidemiol Drug Saf (2000) 0.79
Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins. Prescrire Int (2003) 0.78
Reduction of liver blood flow and propranolol metabolism by cimetidine. N Engl J Med (1981) 3.98
cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol (1992) 2.91
The International Clinical Epidemiology Network (INCLEN): a progress report. J Clin Epidemiol (1991) 2.32
beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol (1994) 1.97
Emergency response to raccoon rabies introduction into Ontario. J Wildl Dis (2001) 1.91
Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol (2001) 1.85
Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects. Br J Clin Pharmacol (1984) 1.69
Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension. J Hum Hypertens (2000) 1.61
Predictors and moderators of response to internet-delivered Interpersonal Psychotherapy and Cognitive Behavior Therapy for depression. J Affect Disord (2013) 1.59
Characterization and expression of a spliced leader RNA in the parasitic nematode Ascaris lumbricoides var. suum. Mol Cell Biol (1989) 1.57
Quality-of-life assessment: patient compliance with questionnaire completion. J Natl Cancer Inst (1992) 1.55
Guidelines for the clinical and economic evaluation of health care technologies. Soc Sci Med (1986) 1.47
Oral administration of misoprostol for labor induction: a randomized controlled trial. Obstet Gynecol (1997) 1.46
A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trial. Br J Rheumatol (1995) 1.43
Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland. Ir Med J (2002) 1.43
Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern Med (1982) 1.43
Alterations in myocardial stiffness in elite athletes assessed by a new Doppler index. Heart (2008) 1.42
Comparison of secondary prevention of heart disease in Europe: lifestyle getting worse, therapy getting better in Ireland. Ir Med J (2002) 1.41
Lack of symptom benefit following presumptive Helicobacter pylori eradication therapy in primary care. Aliment Pharmacol Ther (2001) 1.39
An HPLC method for the determination of the free cortisol/cortisone ratio in human urine. Biomed Chromatogr (2007) 1.38
A brain-damaged patient with an unusual perceptuomotor deficit. Nature (1995) 1.38
Immunolocalization of beta ig-h3 protein in 5q31-linked corneal dystrophies and normal corneas. Arch Ophthalmol (1999) 1.36
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily. Eur J Clin Invest (2009) 1.32
Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol (1997) 1.28
Screening for thyroid dysfunction in diabetics. Br Med J (1979) 1.22
Serum sodium as a risk factor for in-hospital mortality in acute unselected general medical patients. QJM (2008) 1.18
St Johns wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol (2002) 1.18
Lipid lowering drugs. BMJ (1990) 1.17
Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety. Ann Intern Med (1987) 1.16
The diagnostic (problem solving) skill of the neurologist. Experimental studies and their implications for neurological training. Arch Neurol (1972) 1.16
Effect of clinical trial publicity on HRT prescribing in Ireland. Eur J Clin Pharmacol (2006) 1.15
Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci (2000) 1.14
Clozapine-associated diabetes. Am J Med (2001) 1.14
Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci (1995) 1.13
Beta-ig. Molecular cloning and in situ hybridization in corneal tissues. Invest Ophthalmol Vis Sci (1997) 1.10
Beta ig-h3 is synthesized by corneal epithelium and perhaps endotheliumin Fuchs' dystrophic corneas. Curr Eye Res (1996) 1.09
Lung cancer and urban air-pollution in Dublin: a temporal association? Ir Med J (2007) 1.09
Lack of effect of ranitidine on the disposition of lignocaine. Br J Clin Pharmacol (1983) 1.09
Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects. Br J Clin Pharmacol (1984) 1.08
Effect of hypotension on liver blood flow and lidocaine disposition. N Engl J Med (1982) 1.08
Propranolol dosage in thyrotoxicosis. J Clin Endocrinol Metab (1980) 1.06
Use of beta-adrenoceptor blocking drugs in hyperthyroidism. Drugs (1984) 1.05
Acute effect of caffeine on arterial stiffness and aortic pressure waveform. Hypertension (2001) 1.05
Matrix metalloproteinase-9 polymorphism contributes to blood pressure and arterial stiffness in essential hypertension. J Hum Hypertens (2007) 1.04
Pharmacokinetic drug interactions with propranolol. Clin Pharmacokinet (1983) 1.04
Altered plasma protein binding of drugs in thyroid disease. Clin Pharmacokinet (1981) 1.04
Hyperthyroidism in the land of Graves: results of treatment by surgery, radio-iodine and carbimazole in 837 cases. Q J Med (1980) 1.03
Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1999) 1.03
The impact of HIV disease progression on serum lipoproteins. AIDS (1992) 1.03
Impact of an acute medical admission unit on hospital mortality: a 5-year prospective study. QJM (2008) 1.02
Array comparative genomic hybridisation on first polar bodies suggests that non-disjunction is not the predominant mechanism leading to aneuploidy in humans. J Med Genet (2011) 1.02
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. J Clin Oncol (2000) 1.02
Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia. J Rheumatol (1994) 1.01
The increased mortality associated with a weekend emergency admission is due to increased illness severity and altered case-mix. Acute Med (2011) 1.00
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS (2001) 0.99
Relationship between the intensity of physical activity, inactivity, cardiorespiratory fitness and body composition in 7-10-year-old Dublin children. Br J Sports Med (2007) 0.98
Optical tomography: experimental verification of noise theory. Opt Lett (1984) 0.97
Acute effects of stretching are not evident in the kinematics of the vertical jump. J Strength Cond Res (2001) 0.97
The spontaneous reporting of adverse drug reactions by nurses. Br J Clin Pharmacol (1995) 0.97
Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine. Br Med J (Clin Res Ed) (1983) 0.96
Resource utilisation, length of hospital stay, and pattern of investigation during acute medical hospital admission. Postgrad Med J (2004) 0.96
Tumour marker detection in oesophageal carcinoma. Eur J Surg Oncol (1996) 0.96
Experimental neurinoma in tissue culture. Acta Neuropathol (1972) 0.95
Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial. J Cancer Surviv (2013) 0.94
The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration. Br J Clin Pharmacol (1981) 0.94
Enzyme induction and inhibition. Pharmacol Ther (1990) 0.94
The application of prescribing indicators to a primary care prescription database in Ireland. Eur J Clin Pharmacol (2005) 0.94
Cimetidine alters plasma catecholamine levels and cortisol and aldosterone excretion. N Engl J Med (1982) 0.93
Microalbuminuria in inflammatory bowel disease. Gut (1994) 0.93
Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008. Ir J Med Sci (2013) 0.92
New Drugs. Beta-blockers and sympathomimetics. Br Med J (Clin Res Ed) (1983) 0.92
Practical clinical pharmacology. Therapeutic drug monitoring and clinical trials. Br Med J (Clin Res Ed) (1988) 0.92
A cohort study investigating aspirin use and survival in men with prostate cancer. Ann Oncol (2014) 0.91
Calcium antagonists, nitrates, and new antianginal drugs. Br Med J (Clin Res Ed) (1983) 0.91
New drugs. H2 receptor antagonists--cimetidine and ranitidine. Br Med J (Clin Res Ed) (1983) 0.91
Knowledge and attitudes to prescribed drugs in young and elderly patients. Ir Med J (1997) 0.91
Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada. J Wildl Dis (2009) 0.91
Impact of an acute medical admission unit on length of hospital stay, and emergency department 'wait times'. QJM (2005) 0.91
An improved medical admissions risk system using multivariable fractional polynomial logistic regression modelling. QJM (2009) 0.91
Amyloid and Pro501 Thr-mutated (beta)ig-h3 gene product colocalize in lattice corneal dystrophy type IIIA. Am J Ophthalmol (1999) 0.91
Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: a trend analysis. Osteoporos Int (2012) 0.90
Ear lobe crease and coronary heart disease. Ir Med J (1992) 0.90
Reach to grasp: the response to a simultaneous perturbation of object position and size. Exp Brain Res (1998) 0.90
Assessing fruit and vegetable consumption in a 5 a day study targeting rural blacks: the issue of portion size. J Am Diet Assoc (1996) 0.89
Clinical pharmacokinetics and endocrine disorders. Therapeutic implications. Clin Pharmacokinet (1987) 0.89
Propranolol, triiodothyronine, reverse triiodothyronine and thyroid disease. Clin Endocrinol (Oxf) (1979) 0.88
Community-based study of atrial fibrillation and stroke prevention. Ir Med J (2004) 0.88
Effect of the British warning on contraceptive use in the General Medical Service in Ireland. Ir Med J (1998) 0.88
Influence of material deprivation on prescribing patterns within a deprived population. Eur J Clin Pharmacol (2003) 0.88
Influence of media and regulatory changes on prescribing of cotrimoxazole and trimethoprim in Ireland. Pharmacoepidemiol Drug Saf (2000) 0.88
Profound reduction in morphine clearance and liver blood flow in shock. Intensive Care Med (1986) 0.88
Patient and disease profile of emergency medical readmissions to an Irish teaching hospital. Postgrad Med J (2004) 0.88
A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours. Ann Oncol (2000) 0.87
Drug reimbursement in Ireland. Ir Med J (2000) 0.87